Background - Cooperation
Besides in-house development, merger and acquisition, cooperation and alliances are becoming increasingly relevant in the optimization of product portfolios, utilization of infrastructure capacity and the geographical expansion of (biopharmaceutical) companies.
Companies are also faced with the challenge of balancing the benefits of greater flexibility, tailored arrangements and lower capital lockup against looser control and organizational integration.
Ray Harald Puth supports companies in the strategic planning as well as the conceptualization and implementation of their alliance management. During the reconciliation phase with potential partners, all parties can benefit from external mediation and the possibility to clarify expectations, interests and conditions prior to detailed formal negotiations.
A further aspect of “cooperation” and “alliance” is collaboration with other stakeholders and interest groups, particularly providers of health services, physicians and patient representatives.
A large number of concerned parties and interest groups are a characteristic of the health care environment. In many ways patients' convalescence and quality of life can benefit from an ethical collaboration of relevant players, as well as optimal utilization of required resources.
